.svg){kind=icon}
What if you could make confident brand decisions?
Brand and Portfolio Strategy
See the full market with confidence
Fragmented data leads to fragmented decisions. IQVIA brings together market intelligence covering over 90% of global pharma sales, enriched with deep visibility into pipeline development, loss‑of‑protection risk, M&A activity, pricing dynamics, and patient‑level evidence. The result is a trusted baseline of market reality that helps teams align quickly, interpret change correctly, and act with confidence.
Model what’s next—and what it means
Forecasting delivers the greatest value when it clarifies what could change—and what those changes would mean for the brand. Combining brand‑level forecasts with in‑depth country perspectives, IQVIA supports confident investment decisions, launch planning, and portfolio management, based on scenario‑based outputs that enable teams to compare strategic options, quantify the impact of key drivers, and align resources around the choices most likely to shape performance over time.
Maximize value across the lifecycle
A strong pricing strategy is essential to maximizing brand value across the product lifecycle. With an up‑to‑date view of the pricing landscape and the ability to rapidly evaluate options, IQVIA supports confident pricing decisions through an integrated global workspace that brings together governance, scenario testing, and launch sequencing, allowing teams to anticipate downstream impacts, optimize sequencing choices, and strengthen confidence in critical pricing decisions.
Move from hindsight to action
Performance analytics helps brand teams move from hindsight to leading indicators and action. IQVIA applies analytics across commercial and real‑world data to track performance, detect early signals of access friction or competitive displacement, and refine strategy. By integrating large‑scale healthcare datasets—including claims, prescriptions, and electronic health records—teams gain a clearer view of patient volumes, diagnosed populations, and where to intervene to protect and grow brand performance.
Validate assumptions with real-world insight
Primary market research strengthens brand strategy by revealing the drivers behind stakeholder choices, including perceptions, behaviors, and unmet needs. IQVIA’s tailored qualitative and quantitative research helps brands refine positioning, test value propositions, and assess messaging relevance end to end. When combined with broader market and performance data, these insights provide critical context to validate strategic assumptions, sharpen differentiation, and track the impact of brand decisions over time.
Connect strategy that stays resilient
Built on IQVIA’s industry‑leading data foundation, AI enables teams to prioritize opportunities faster, refine access strategies, respond quickly to market shifts, and improve consistency across critical decisions. Brand teams will be able to strengthen decisions by synthesizing market data, research insights, and performance signals into clear strategic direction.
Achieve Launch Excellence
With over three decades of experience and a deep analysis of over 1000 innovative launches, IQVIA knows what it takes to achieve launch excellence. IQVIA offers end-to-end strategic support throughout launch planning, execution and monitoring.
Optimize Established Brands
Sustained growth of mature brands requires a different approach. IQVIA Established Brands Optimization is a consultative method to reinvigorate brand profitably in late commercial phases, focusing on analytics, field resourcing and marketing services.
IQVIA MIDAS®
MIDAS delivers harmonized global pharmaceutical market intelligence by integrating industry‑leading sales, medical, disease, and patient-level data to enable accurate market sizing, performance benchmarking, and confident decisions worldwide.
IQVIA Analytics Link
The Analytics Link Ecosystem delivers a connected view of the pharmaceutical market by connecting sales, patients, pipeline, launches, protection, deals, and 10‑year forecasts. This unified perspective enables robust assessment of your business and competitors’ market dynamics across drugs, diseases, and countries, supporting more confident, forward‑looking decisions.
IQVIA Market Prognosis
MIDAS delivers harmonized global pharmaceutical market intelligence by integrating industry‑leading sales, medical, disease, and patient-level insights to enable accurate market sizing, performance benchmarking, and confident decisions worldwide.
IQVIA Primary Intelligence
Market Prognosis provides a forward‑looking view of how pharmaceutical markets are expected to evolve, helping brand teams plan with greater confidence. Built on validated, syndicated market forecasts, it brings clarity to future demand, competitive dynamics, and key market drivers across geographies and therapy areas.Brand and Portfolio Strategy: Frequently Asked Questions
Evaluating pipeline viability requires a connected view of global market data, real‑world evidence, and primary market research. IQVIA’s Brand Strategy approach integrates pipeline intelligence, disease and market dynamics, physician and patient insights, and long‑range forecasts to assess unmet need, competitive risk, and commercial potential. This lifecycle‑driven perspective enables earlier, more confident portfolio and investment decisions.
Pharmaceutical manufacturers can maximize brand performance by continuously monitoring market signals across sales, promotion, pipeline activity, and stakeholder sentiment. IQVIA combines global market intelligence, advanced analytics, and AI‑powered insights to move beyond static reporting toward forward‑looking decision‑making. This enables teams to anticipate change, refine strategy, and respond faster to evolving competitive and market dynamics.
IQVIA provides AI‑driven forecasting and commercial analytics. Solutions such as Market Prognosis, Analytics Link Ecosystem, and AI‑enabled market intelligence connect historical performance with future outlooks. This integrated approach supports more accurate launch planning, demand forecasting, and in‑market optimization across geographies and therapy areas.
Brand leaders can generate actionable brand insights by unifying data across sales, patients, pipeline, launches, and primary research. IQVIA’s Brand Strategy solutions connect syndicated data, proprietary real‑world evidence, and primary intelligence into a single analytical ecosystem. This connected foundation enables deeper insight, clearer prioritization, and more confident brand planning across the product lifecycle.
Speak to an expert
Ready to accelerate your brand impact?
Schedule a demo or speak with one of our experts to discuss how IQVIA can help optimize your brand and portfolio strategy.
INDUSTRY ARTICLE
From Dashboards to Decisions: How AI is Reshaping Pharma Brand Strategy
Pharma teams have more data than ever — but when measurement lags by 12–18 months, brand strategy is shaped by what teams can react to, not what they can shape.
This Pharmaceutical Executive article explores how AI is closing the gap between insight and action, helping teams move beyond dashboards to make more confident brand decisions.
Industry Article
From weeks to minutes: How AI transforms pharma market entry strategy
In this Pharmaphorum article, discover how agentic AI transforms market entry decisions from weeks to minutes. Learn how pharmaceutical organizations unify fragmented sales, promotional, and competitive data through natural language queries - delivering real-time strategic insights that accelerate launch success.